Jul 27, 2012 — Researchers say that expanding anti-retroviral treatment to all HIV-positive people in couples with one partner who isn't infected is cost-effective even in developing countries with limited budgets.
Jul 23, 2012 — The leading international AIDS conference returns to the U.S. after a 22-year hiatus. A lot has happened in the years since the conference was last here. Treatments have turned a disease with a near-certain death sentence into a disease that people can live with for decades. And there is evidence that the epidemic could be greatly slowed or even stopped.
Jul 19, 2012 — Each year hundreds of thousands South Africans become infected with HIV, so it might seem that a drug to slow transmission would be welcome. But there's concern about unintended consequences if Truvada is used widely for prevention.
Jul 17, 2012 — Some Brazilian researchers say Truvada should only be given to very specific groups at risk of getting HIV, like young, gay men. Others are concerned that a drug that blocks the transmission of HIV could be a set-back for safe sex campaigns and might actually encourage unsafe sexual behavior.
Jul 17, 2012 — Truvada, the first HIV prevention pill, costs about $13,000 a year, and it's not clear whether insurers will pay for it. And while taking a daily pill sounds simple, the new prevention strategy involves some complicated issues.
Jul 16, 2012 — The drug was approved for people who test negative for HIV infection. It's supposed to be used in combination with safe-sex practices, such as using a condom, to reduce infection risk.
Nov 24, 2010 — In the first hour of Talk of the Nation, the political junkie, and the promise of an HIV pill. In our second hour, a Mickey Mantle biography that shows the hero and the human being, and traveling while fat.